Endoxan 50 mg obložene tablete
| Name | Endoxan 50 mg obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-921138904 |
| Active Substance | ciklofosfamid hidrat |
| Composition | jedna obložena tableta sadrži 50 mg ciklofosfamida u obliku ciklofosfamid hidrata |
| Pharmaceutical Form | obložena tableta |
| Manufacturer | Baxter Oncology GmbH, Halle (Westfalen), Njemačka |
| Marketing Authorisation Holder | Baxter d.o.o., Letališka cesta 29A, Ljubljana, Slovenija |
| Marketing Authorisation Date | 26.04.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/282 |
| Registration Number | 381-12-01/30-19-10 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01AA01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
